Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Del Giudice, Ginevra ^a   Bianco, Andrea ^b   Cennamo, Antonio ^a   Santoro, Giulia ^c   Bifulco, Marco ^c   Marzo, Carlo ^a   Mazzarella, Gennaro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c Hospital Dei Colli   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AORTOPULMONARY SEPTAL DEFECT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LUNG LESION; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; NONTUBERCULOUS MYCOBACTERIAL DISEASE; PET-CT SCANNER; PLEURA EFFUSION; PLEURA THICKENING; TUBERCULOSIS; WHOLE BODY SCANNER; BACTERIAL PNEUMONIA; DIAGNOSTIC IMAGING; LUNG; LYMPH NODE; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIOSIS; MYCOBACTERIUM; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; HUMANS; LUNG; LYMPH NODES; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PNEUMONIA, BACTERIAL; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY;

EID: 84935882007     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/353202     Document Type: Article

References (20)

1. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases," The American Journal of Respiratory and Critical CareMedicine, vol. 175, no. 4, pp. 367-416, 2007.
2. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases," The American Journal of Respiratory and Critical CareMedicine, vol. 175, no. 4, pp. 367-416, 2007.
3. G. del Giudice, C. Iadevaia, G. Santoro, E. Moscariello, R. Smeraglia, and C. Marzo, "Nontuberculous mycobacterial lung disease in patients without HIV infection: a retrospective analysis over 3 years," Clinical Respiratory Journal, vol. 5, no. 4, pp. 203-210, 2011.
4. E. M. Lincoln and L. A. Gilbert, "Disease in children due to mycobacteria other than Mycobacterium tuberculosis," The American Review of Respiratory Disease, vol. 105, no. 5, pp. 683-714, 1972.
5. R. Hazra, C. D. Robson, A. R. Perez-Atayde, and R. N. Husson, "Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy," Clinical Infectious Diseases, vol. 28, no. 1, pp. 123-129, 1999.
6. H. Schoder and M. Gonen, "Screening for cancer with PET and PET/CT: potential and limitations," Journal ofNuclearMedicine, vol. 48, no. 1, pp. 4S-18S, 2007.
7. L. Brunese, B. Greco, F. R. Setola et al., "Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology," Medical Science Monitor, vol. 19, no. 1, pp. 95-101, 2013.
8. A. S. Teirstein, J. Machac, O. Almeida, P. Lu, M. L. Padilla, and M. C. Iannuzzi, "Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis," Chest, vol. 132, no. 6, pp. 1949-1953, 2007.
9. J. J. Braun, R. Kessler, A. Constantinesco, and A. Imperiale, "18FFDGPET/CT in sarcoidosismanagement: Reviewand report of cases," European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 8, pp. 1537-1543, 2008.
10. M. M. Schuurmans, A. Ellmann, H. Bouma, A. H. Diacon, K. Dyckmans, and C. T. Bolliger, "Solitary pulmonary nodule evaluation with 99mTc-methoxy isobutyl isonitrile in a tuberculosis-endemic area," European Respiratory Journal, vol. 30, no. 6, pp. 1090-1095, 2007.
11. A. Bianco, G. Mazzarella, D. Rocco, M. Gasperi, R. di Marco, and L. Brunese, "FDG/PET uptake in asymptomatic multilobar chlamydia pneumoniae pneumonia," Medical Science Monitor, vol. 16, no. 6, pp. CS67-CS70, 2010.
12. B. J. Krause, S. Schwarzenbock, and M. Souvatzoglou, "FDG PET and PET/CT," Recent Results in Cancer Research, vol. 187, pp. 351-369, 2013.
13. J. M. Goo, J. G. Im, K. H. Do et al., "Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases," Radiology, vol. 216, no. 1, pp. 117-121, 2000.
14. S. Bandoh, J. Fujita, Y. Ueda et al., "Uptake of fluorine-18-fluorodeoxyglucose in pulmonary Mycobacterium avium complex infection," Internal Medicine, vol. 42, no. 8, pp. 726-729, 2003.
15. W. Matsuyama, M. Yamamoto, K.-I. Oonakahara et al., "Intense 18F-fluorodeoxyglucose uptake caused by pulmonary Mycobacteriumintracellulare infection," Nihon Kokyuki Gakkai Zasshi, vol. 42, no. 11, pp. 970-974, 2004.
16. Y. Demura, T. Tsuchida, D. Uesaka et al., "Usefulness of 18Ffluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis," European Journal of NuclearMedicine andMolecular Imaging, vol. 36, no. 4, pp. 632-639, 2009.
17. S. L. Davis, E. L. Nuermberger, P. K. Um et al., "Noninvasive pulmonary 18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment," Antimicrobial Agents and Chemotherapy, vol. 53, no. 11, pp. 4879-4884, 2009.
18. R. Condos, W. N. Rom, Y. M. Liu, and N. W. Schluger, "Local immune responses correlate with presentation and outcome in tuberculosis," American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, part 1, pp. 729-735, 1998.
19. G. Mazzarella, A. Bianco, F. Perna et al., "T lymphocyte phenotypic profile in lung segments affected by cavitary and noncavitary tuberculosis," Clinical and Experimental Immunology, vol. 132, no. 2, pp. 283-288, 2003.
20. A. Sanduzzi, F. Perna, M. Galgani, A. Bianco, and G. Mazzarella, "Lung and peripheral blood T lymphocytes IFN-γ production in infliximab-associated pulmonary tuberculosis," Respiratory Medicine Extra, vol. 1, no. 2, pp. 17-19, 2005.